Vertex Pharmaceuticals (VRTX)

Operating Income Growth

24.17%

TTM · Period ending:

VRTX logo

VRTX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported24.17%
VRTX TTM Operating Income YoY % (12.20% → 24.17%)
High-resolution chart · PNG

VRTX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-198.5126%
12.8677%
9.1972%
61.086%
53.7412%
8.1959%
-17.3554%
-86.8852%
-32.5513%
-72.7626%
-91.0526%
-69.4444%
-73.0964%
4.1045%
36.2416%
32.3308%
27.5735%
8.2192%
-12.4528%
18.4049%
4.2254%
-24.2553%
-27.4038%
-757.8947%
-879.3103%
-1,666.6667%
-1,833.3333%
63.1068%
71%
113.2743%
112.1212%
-18.3908%
-33.3333%
-73.8462%
-175%
-12.987%
-31.5789%
-71.0526%
12.1951%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.